Vicarious Surgical (RBOT) Income from Non-Controlling Interests (2020 - 2021)
Vicarious Surgical's (RBOT) quarterly Income from Non-Controlling Interests came in at -$21.0 million in Q2 2021, down 78652.22% year-on-year from N/an in Q2 2020, and down 78652.22% on a QoQ basis from -$26704.0 in Q2 2020.
Vicarious Surgical (RBOT) Income from Non-Controlling Interests (2020 - 2021) Analysis & Trends
Vicarious Surgical (RBOT) has 2 years of Income from Non-Controlling Interests data on file, last reported at -$21.0 million in Q2 2021.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inc. Minority (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 184.08 Bn | 176.78 Bn | 6.27 Bn | - |
| 2 | Stryker | 128.96 Bn | 126.08 Bn | 3.81 Bn | - |
| 3 | Medtronic | 108.90 Bn | 99.68 Bn | 6.41 Bn | 16.00 Mn |
| 4 | Boston Scientific | 68.58 Bn | 67.13 Bn | 3.61 Bn | -2.00 Mn |
| 5 | Edwards Lifesciences | 48.33 Bn | 44.66 Bn | 1.29 Bn | - |
| 6 | Dexcom | 28.45 Bn | 27.33 Bn | 750.30 Mn | - |
| 7 | GE HealthCare Technologies | 28.36 Bn | 26.08 Bn | 1.98 Bn | 22.00 Mn |
| 8 | Smith & Nephew | 26.96 Bn | 26.38 Bn | - | - |
| 9 | Koninklijke Philips | 25.43 Bn | 22.31 Bn | 2.07 Bn | -5.85 Mn |
| 10 | Vicarious Surgical | 625,212.51 | -9.17 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2021 | -21.03 Mn |
| Jun 30, 2020 | -26,704.00 |